GGrantIndex
Sort

50,496 grants matching lung cancer

Cancer Immunotherapy Clinical Trials

$607,000
Christopher Heery · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

A Noninvasive Integrated Genomic Approach for Early Cancer Detection and Risk Stratification after Transplantation

$606,977
Kiran Kaur Khush · Stanford University · R01 · FY2020 · CA

IDENTIFICATION AND FUNCTION OF ETS TARGET GENES INVOLVED IN LUNG CANCER PROGRESSION

$606,976
Trustees Of Boston University · · FY2010 · Department of Defense

Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma

$606,975
Xiaoxin Chen · Coriell Institute For Medical Research · R01 · FY2024 · CA

Enhancing cancer outreach for low-income adults with innovative smoking cessation

$606,906
Alexander V Prokhorov · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA

Autoimmunity in Cardiopulmonary Toxicities from Radiotherapy andImmunotherapy

$606,856
Bo Lu · University Of Missouri-Columbia · R01 · FY2023 · CA

Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer

$606,797
Jia Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

Thyroid StemProgenitor Cells

$606,780
Shioko Kimura · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Establishing a mechanistic basis for enhanced tumorigenesis under chronic circadian disruption

$606,729
Katja A Lamia · Scripps Research Institute, The · R01 · FY2025 · CA

MeV: Software for Next Generation Genomic Data Analysis

$606,717
John Quackenbush · Dana-Farber Cancer Inst · U01 · FY2012 · CA

6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification

$606,672
David M. Ashley · Duke University · U19 · FY2021 · CA

Canadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network

$606,669
Janet Ellen Dancey · Queen'S University At Kingston · U10 · FY2019 · CA

Canadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network: Statistics and Data Management Core

$606,668
Janet Ellen Dancey · Queen'S University At Kingston · U10 · FY2019 · CA

Canadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network: Clinical Trials Development & Member Site Core

$606,668
Janet Ellen Dancey · Queen'S University At Kingston · U10 · FY2019 · CA

Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment

$606,587
Mizuki Nishino · Brigham And Women'S Hospital · R01 · FY2017 · CA

Translation of a Lung Cancer Palliative Care Intervention for Clinical Practice

$606,580
Betty R Ferrell · Beckman Research Institute/City Of Hope · R01 · FY2017 · NR

Stationary Anti-scatter Grids for Digital Breast Imaging

$606,543
Cha-Mei Tang · Creatv Microtech, Inc. · R44 · FY2010 · CA

Integrating Evidence-Based Smoking Cessation Interventions into Lung Cancer Screening Programs: A Randomized Trial

$606,515
Kathryn L Taylor · Georgetown University · R01 · FY2017 · CA

Development of FISH Molecular Diagnostics to support Clinical Trials at NCI

$606,510
Liqiang Xi · Division Of Basic Sciences - Nci · ZID · FY2024 · CA

Prostate Cancer Diagnosis by Multiparametric Ultrasound

$606,458
Ethan J Halpern · Thomas Jefferson University · R01 · FY2021 · CA

Compounded Neuronal Damage in Comorbid Cigarette Smoking and Addiction

$606,456
Karmen K Yoder · Indiana University Indianapolis · R01 · FY2018 · AA

The role of Tet1 in myofibroblast differentiation

$606,430
Sem H Phan · University Of Michigan At Ann Arbor · R01 · FY2021 · HL

Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons

$606,318
Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2012 · CA

Clinical Trials with Immunotoxins

$606,310
Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Targeting Fibroblast Discoidin Domain Receptor 2 for Immunotherapy to Pulmonary Fibrosis

$606,273
Kevin Keewoun Kim · University Of Michigan At Ann Arbor · R01 · FY2023 · HL